A Barentz Representative will be in touch shortly
LATEST COMMODITIES REPORT
Selling prices of select raw materials and currencies
2025-October-Commodities-ReportTRADESHOWS
March 10, 2024
Barentz announces strategic distribution agreement with Evonik for AvailOm® Omega – 3 Lysine complex in Canada.
Barentz, a leading global life science and specialty performance ingredients distributor, has signed a new distribution agreement with Evonik, one of the world leaders in specialty chemicals, to distribute its AvailOm® Omega-3 Lysine complex in Canada, effective March 10, 2024. This strategic partnership signifies a mutual commitment to expanding market reach and enhancing customer satisfaction. Under this agreement, Evonik will leverage Barentz’s extensive distribution network to bring AvailOm® to a broader audience in Canada, while Barentz will benefit from offering their customers access to cutting-edge solutions.
Read MoreJanuary 5, 2024
Barentz Announces a New Distribution Agreement for Ashland Vialose™ trehalose dihydrate parenteral excipient in the United States.
Barentz, a leading global life science and specialty performance ingredients distributor, has signed a distribution agreement with Ashland Inc., a global additives and specialty ingredients company, that covers its Vialose™ trehalose dihydrate functional ingredient in the United States, effective January 1, 2024.
Read MoreNovember 1, 2023
Barentz Wins the Capitalizer Award - 2023 Modern Accounting Awards from Blackline
Barentz, a leading global distributor of life science and specialty performance ingredients throughout North America, is honored to accept the Capitalizer Award from Blackline’s 2023 Modern Accounting Awards for revolutionizing traditional accounting methods to adopt modern accounting practices.
Read MoreJune 20, 2023
Barentz Announces Grand Opening of State-of-the-Art Pharmaceutical Development Center.
Barentz, a global leading distributor of life science ingredients, is thrilled to announce the grand opening of its new, cutting-edge pharmaceutical development center. This state-of-the-art facility represents a significant milestone in our commitment to innovation and will serve as a collaboration hub for pharmaceutical and nutraceutical manufacturers in North America.
Read MoreMarch 22, 2023
Barentz Expands Market Acceleration Team
Barentz, a leading global distributor of life science ingredients, is excited to welcome Bryan Daniels, as the new Market Acceleration Group Director. Daniels brings to Barentz more than two decades of progressive sales and leadership experience gained by building talented, performance-driven teams and initiating strategic plans to promote sales growth. He is a highly motivated, results-driven business professional with extensive experience maximizing revenue and market share, leading initiatives from conception to execution.
Read MoreFebruary 13, 2023
Barentz announces North American leadership transition
Barentz announces a planned leadership transition in its North America business. Mike McKenna who previously served as President & COO North America, will become CEO North America. Terry Hill, former CEO, will join the company's Supervisory Board. These appointments are effective March 1, 2023.
Read More